Novel immune regulation mechanism involving Natural Killer Cells described and published in "Science" magazine by a key academic partner of Innate Pharma
Half-year report on Innate Pharma's liquidity contract with Natixis Securities
Innate Pharma announces its financial calendar for 2012 as well as its participations to upcoming investor conferences
Innate Pharma SA announces its participation in Actionaria on November 18 & 19 in Paris
Innate Pharma announces its turnover for the first nine months of 2011 and updates on its cash position
Innate Pharma to present at two upcoming investor conferences
Financial results for the first half of 2011
Half-year report on Innate Pharma's liquidity contract with Natixis Securities
Bristol-Myers Squibb and Innate Pharma Announce Breakthrough Global License Agreement for an Investigational Immuno-Oncology Biologic
Innate Pharma announces today the outcome of its Annual General Meeting which took place on June 29, 2011, in Marseilles, France
